ÂÜÀòÂÒÂ×

Fabian, having joined SCHOTT AG in 2012, is Vice President Global Strategy & Innovation for the SCHOTT Business Unit Pharmaceutical Systems. Within the management team he is responsible for strategy, product management, product development, IP management and market intelligence. Prior to this, he was heading the corporate strategy department of SCHOTT AG being responsible for corporate development, strategic planning and portfolio management of the whole group. Before joining SCHOTT, Fabian worked as a project manager at PriceWaterhouseCoopers AG focusing the pharma/life science, biotech and chemical industries where he advised international clients on strategy definition and implementation, reorganization and restructuring, M&A transactions, commercial and financial due diligence, company valuation, financial reporting valuation and impairment testing. Fabian has profound expertise dealing with strategic as well as operational challenges and a long-standing experience leading international and cross-functional teams. His structured and pragmatic approach balances required results with entrepreneurial spirit and cultural needs. Fabian studied business administration at the University of Cologne/Germany and the Corvinus University of Budapest/Hungary and holds an MBA from the University of Cologne. He is a Chartered Financial Analyst (CFA) charterholder from the CFA Institute, Charlottesville/USA.